Wed. Jul 6th, 2022
Covid Vaccine: Zydus Cadila completes phase-2 trial, to submit data in November MD Sharvil Patel says company plans to begin phase-3 in December, upon approval, and expects to have final data by March-April 2021. The company plans to test the ZyCoV-D vaccine on about 15,000-20,000 people in Phase-3 and is hopeful of launching it in the first half of 2021.